Loading chat...
PA SB866
Bill
Status
7/24/2025
Primary Sponsor
Michele Brooks
Click for details
AI Summary
-
Adds medetomidine (including any compound, mixture, or preparation containing it) to Schedule III of Pennsylvania's controlled substances list
-
Exempts medetomidine from controlled substance classification when used for approved veterinary purposes, including FDA-approved animal drugs, investigational animal drugs, and pharmaceutical compounding by licensed pharmacists or veterinarians
-
Requires veterinarians to securely store medetomidine under the same Pharmacy Act provisions already applicable to xylazine storage
-
Takes effect immediately upon enactment
Legislative Description
Further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.
Last Action
Referred to Agriculture & Rural Affairs
7/24/2025